Skip to main content
Top
Published in: Diabetologia 7/2006

01-07-2006 | Letter

Reply to comment on: Høi-Hansen T, Pedersen-Bjergaard U, Thorsteinsson B (2005) The Somogyi phenomenon revisited using continuous glucose monitoring in daily life. Diabetologia 48:2437–2438

Authors: T. Høi-Hansen, U. Pedersen-Bjergaard, B. Thorsteinsson

Published in: Diabetologia | Issue 7/2006

Login to get access

Excerpt

To the Editor: Thank you for giving us the opportunity to respond to the letter from Iseda et al. [1]. We certainly acknowledge the extensive scientific contribution made by Dr Somogyi [2]. He concluded, amongst other things, after studying five patients that ‘excessive glycosuria (hyperglycemia) is an aftermath of hypoglycemia’ [3]. With the years, this phrase has been interpreted as nocturnal hypoglycaemia inducing high morning blood glucose values [4]. In our letter we rejected this clinical statement by showing that if patients have a nocturnal hypoglycaemic episode during the night there was a high probability that blood glucose the following morning was low [5]. This finding suggests that hormonal counter-regulation alone is not capable of inducing hyperglycaemic excursions in type 1 diabetic patients. Iseda et al. now raise the question of whether hyperglycaemia occurs later on in the day after a nocturnal hypoglycaemic episode. In this context it should be noted that the glycaemic response during the day after a night with hypoglycaemia is a complex result of carbohydrate intake (sometimes increased by the hypoglycaemic episode), insulin dosage (possibly reduced if morning glucose is low), prolonged action of counter-regulatory hormones (primarily cortisol and growth hormone), physical activity and other factors. This means that a hyperglycaemic excursion after an episode of nocturnal hypoglycaemia may be caused by reasons other than pure counter-regulatory insulin resistance. Nevertheless, we consider the question to be of clinical importance and have looked further into our data by studying hourly glucose values determined by a continuous glucose monitoring system (CGMS) for 4 h post-breakfast (Fig. 1) and the maximum value during the day.
Literature
1.
go back to reference Iseda I, Lins PE, Adamson U, Kollind M (2006) Comment to: Hoi-Hansen T, Pedersen-Bjergaard U, Thorsteinsson B (2005) The Somogyi phenomenon revisited using continuous glucose monitoring in daily life. Diabetologia 48:2437–24–38. Diabetologia. DOI:10.1007/s00125-006-0238-z Iseda I, Lins PE, Adamson U, Kollind M (2006) Comment to: Hoi-Hansen T, Pedersen-Bjergaard U, Thorsteinsson B (2005) The Somogyi phenomenon revisited using continuous glucose monitoring in daily life. Diabetologia 48:2437–24–38. Diabetologia. DOI:10.1007/s00125-006-0238-z
5.
go back to reference Høi-Hansen T, Pedersen-Bjergaard U, Thorsteinsson B (2005) The Somogyi phenomenon revisited using continuous glucose monitoring in daily life. Diabetologia 48:2437–2438CrossRefPubMed Høi-Hansen T, Pedersen-Bjergaard U, Thorsteinsson B (2005) The Somogyi phenomenon revisited using continuous glucose monitoring in daily life. Diabetologia 48:2437–2438CrossRefPubMed
Metadata
Title
Reply to comment on: Høi-Hansen T, Pedersen-Bjergaard U, Thorsteinsson B (2005) The Somogyi phenomenon revisited using continuous glucose monitoring in daily life. Diabetologia 48:2437–2438
Authors
T. Høi-Hansen
U. Pedersen-Bjergaard
B. Thorsteinsson
Publication date
01-07-2006
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 7/2006
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-006-0284-6

Other articles of this Issue 7/2006

Diabetologia 7/2006 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.